Back to search
FDAFDA · Food and drugs·Recall number D-0803-2026

Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2

Published September 2, 2026 · Recall initiated: August 6, 2026

Summary

FDA records drug Class II recall D-0803-2026, published September 2, 2026 and initiated August 6, 2026. Recalling firm: Mallinckrodt Hospital Products Inc.; Status: Ongoing; Reported quantity: 12367 vials; Lot: Lot#: NDC 63004-8710-1 - 1564-107, exp 1/31/2027 NDC 63004-8710-2 - 1564-107H, exp 1/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of particulate matter: glass and stopper piece

What to do

Voluntary: Firm initiated · Letter

Get an email if ACTHAR has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ACTHAR
Manufacturer
Mallinckrodt Hospital Products Inc.
Distributor
USA Nationwide
UPC
0363004871213
Lot
Lot#: NDC 63004-8710-1 - 1564-107, exp 1/31/2027 NDC 63004-8710-2 - 1564-107H, exp 1/31/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2 recalled?

Yes. FDA published recall D-0803-2026 on September 2, 2026. Reported hazard: Presence of particulate matter: glass and stopper piece

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ACTHAR. UPC: 0363004871213.